Trevi Therapeutics, Inc.TRVINASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank89
Studio
Year-over-Year Change

Return on equity

Latest
-23.33%
↑ 64% vs avg
Percentile
P89
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-64.24%
Historical baseline
PeriodValueYoY Change
2025-23.33%+51.5%
2024-48.08%-36.6%
2023-35.21%-29.8%
2022-27.13%+86.4%
2021-198.77%-65.5%
2020-120.07%-151.4%
2019-47.76%+59.8%
2018-118.71%-36.4%
2017-87.02%-236.7%
201663.68%-